Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131595) titled 'Efficacy and Safety of Consolidative Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer in the Immunotherapy Era: A Multicenter Real-World Cohort Study' on Sept. 4.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Taizhou Cancer Hospital
Condition:
Extensive-Stage Small Cell Lung Cancer
Intervention:
Radiotherapy group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: Radiotherapy group:300;Non-radiotherapy group:700;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...